|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 25,450 KRW | -1.17% |
|
+9.46% | -1.55% |
| 2023 | NeoPharm CO., LTD. Reports Earnings Results for the First Quarter Ended March 31, 2023 | CI |
| 2019 | NeoPharm CO., LTD. announced that it has received KRW 31.970667276 billion in funding | CI |
NeoPharm CO., LTD. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was KRW 11.13 million compared to KRW 4.84 million a year ago. Net income was KRW 6,808.52 million compared to KRW 4,924.02 million a year ago.
Basic earnings per share from continuing operations was KRW 871 compared to KRW 630 a year ago. Basic earnings per share was KRW 871 compared to KRW 630 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -1.55% | 146M | |
| +10.09% | 18.86B | |
| 0.00% | 17.37B | |
| -1.32% | 10.65B | |
| -7.81% | 10.26B | |
| +7.52% | 6.72B | |
| +10.34% | 5.94B | |
| +0.06% | 4.55B | |
| -19.01% | 3.83B | |
| -3.97% | 3.48B |
NEOPHARM CO., LTD. 
